Symrise peptides available
This article was originally published in The Rose Sheet
Executive Summary
Ingredient supplier's purchase of a 20% stake in Louisiana-based Therapeutic Peptides Inc. gives it exclusive distribution rights to "ultra-innovative group of active ingredients known as peptides," used in personal-care products for their anti-microbial and anti-aging benefits, as well as to stimulate hair growth, firm says Aug. 19. "We are delighted to be able to integrate these modern and very effective ingredients in our portfolio. With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field," says Symrise's Dr. Klaus Stanzl, president scent & care, life essentials, who has been elected to TPI's supervisory board. Symrise recently expanded its organic botanicals offering to include Bayliss Ranch's USDA-certified AllPlant Essence line (1"The Rose Sheet" Aug. 18, 2008, p. 7)
You may also be interested in...
Symrise Grows Organic Portfolio With USDA-Certified AllPlant Essence Line
Ingredient supplier Symrise has extended its organic botanicals offering to include a line of water-soluble plant extracts certified organic by the U.S. Department of Agriculture's Natural Organic Program
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.